Rexahn Pharmaceuticals, Inc. (RNN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.62, down from yesterday’s close by -7.90%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Money managers are always interested in a company that can find the right recipe of fundamental data because it reflects something important going on underneath the surface. Rexahn Pharmaceuticals, Inc. (RNN) currently trades with a market capitalization of $143.36 Million.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For RNN, the company currently has $11.58 Million of cash on the books. You can get a sense of how sustainable that is by a levered free cash flow of $-13.23 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Perhaps, that suggests something about why 15.33% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Rexahn Pharmaceuticals, Inc. recorded a 52-week high of $0.71. It is now trading 0.09% off that level. The stock is trading $0.36 its 50-day moving average by -0.26%. The stock carved out a 52-week low down at $0.13.
In recent action, Rexahn Pharmaceuticals, Inc. (RNN) has made a move of +34.78% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is outperforming the S&P 500 by 80.56, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 4.59% with $230.21 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of RNN.